Pubblicazioni - Istituto Nazionale dei Tumori

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI - MILANO
S.C. EPIDEMIOLOGIA ANALITICA E IMPATTO SANITARIO
ELENCO PUBBLICAZIONI (aggiornato a novembre 2014)
1.
Micheli A, Meneghini E, Mariottini M, Baldini M, Baili P, Di Salvo F, Sant M. Risk of death for
hematological malignancies for residents close to an Italian petrochemical refinery: a population-based casecontrol study. Cancer Causes Control. 2014 [Epub ahead of print]
2.
Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M,
Monnereau A, Osca-Gelis G, Visser O, De Angelis R; EUROCARE-5 Working Group. Survival for
haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE5, a population-based study. Lancet Oncol. 2014;15(9):931-42.
3.
Minicozzi P, Bouvier AM, Faivre J, Sant M; Study working group. Management of rectal cancers in
relation to treatment guidelines: a population-based study comparing Italian and French patients. Dig Liver
Dis. 2014;46(7):645-51.
4.
Di Salvo F, Baili P, Vicentini M, Tumino R, Vercelli M, Pirino D, Contiero P, Foschi R, Minicozzi P,
Giorgi Rossi P, De Lorenzo F, Micheli A; CAREMORE Group. Cancer rehabilitation services: an Italian
population-based cohort study. Tumori. 2014;100(3):346-51
5.
Minicozzi P, Kaleci S, Maffei S, Allemani C, Giacomin A, Caldarella A, Iachetta F, Fusco M, Tumino R,
Vicentini M, Falcini F, Cesaraccio R, Ponz de Leon M, Sant M. Disease presentation, treatment and survival
for Italian colorectal cancer patients: a EUROCARE high resolution study. Eur J Public Health.
2014;24(1):98-100.
6.
European Partnership Action Against Cancer consensus group, Borras JM, Albreht T, Audisio R, Briers E,
Casali P, Esperou H, Grube B, Hamoir M, Henning G, Kelly J, Knox S, Nabal M, Pierotti M, Lombardo C,
van Harten W, Poston G, Prades J, Sant M, Travado L, Valentini V, van de Velde C, van den Bogaert S, van
den Bulcke M, van Hoof E, van den Neucker I, Wilson R. Policy statement on multidisciplinary cancer
care.Eur J Cancer. 2014;50(3):475-80.
7.
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour
B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C,
Tavilla A, Trama A, Visser O, Peris-Bonet R; EUROCARE Working Group. Childhood cancer survival in
Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol. 2014 ;15(1):35-47.
Erratum in: Lancet Oncol. 2014;15(2):e52.
8.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H,
Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a
population-based study. Lancet Oncol. 2014;15(1):23-34.
9.
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour
B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C,
Tavilla A, Trama A, Visser O, Peris-Bonet R; the EUROCARE Working Group. Childhood cancer survival
in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol. 2013 Dec 4
10. Minicozzi P, Berrino F, Sebastiani F , Falcini F , Vattiato R, Cioccoloni F, Calegreti G, Fusco M, Vitale MF,
Tumino R, Sigona A, Budroni M, Cesaraccio R, Candela G, Scuderi T, Zarcone M, Campisi I, Sant M. High
fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in
hormone receptor-positive disease. Eur J Cancer. 2013 Sep 3 [Epub ahead of print]
11. Minicozzi P, Bella F, Toss A, Giacomin A, Fusco M, Zarcone M, Tumino R, Falcini F, Cesaraccio R,
Candela G, La Rosa F, Federico M, Sant M. Relative and disease-free survival for breast cancer in relation
to subtype: a population-based study. J Cancer Res Clin Oncol. 2013 Sep;139(9):1569-77
12. Bella F, Minicozzi P, Giacomin A, Crocetti E, Federico M, Ponz de Leon M, Fusco M, Tumino R, Mangone
L, Giuliani O, Budroni M, Sant M. Impact of diabetes on overall and cancer-specific mortality in colorectal
cancer patients. J Cancer Res Clin Oncol. 2013 Aug;139(8):1303-10
13. Bouvier AM, Minicozzi P, Grosclaude P, Bouvier V, Faivre J, Sant M. Patterns of adjuvant chemotherapy
for stage II and III colon cancer in France and Italy. Dig Liver Dis. 2013 Aug;45(8):687-91
14. Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R; EUROCARE Working Group.
Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol. 2013 Jun;24(6):1660-6
15. Minicozzi P, Kaleci S, Maffei S, Allemani C, Giacomin A, Caldarella A, Iachetta F, Fusco M, Tumino R,
Vicentini M, Falcini F, Cesaraccio R, Ponz de Leon M, Sant M. Disease presentation, treatment and survival
for Italian colorectal cancer patients: a EUROCARE high resolution study. Eur J Public Health. 2013 May
31
16. Mangone L, Minicozzi P, Vicentini M, Giacomin A, Caldarella A, Cirilli C, Falcini F, Giorgi Rossi P, Sant
M. Key factors influencing lung cancer survival in northern Italy. Cancer Epidemiol 2013 Jun;37(3):22632
17. Allemani C, Minicozzi P, Berrino F, Bastiaannet E, Gavin A, Galceran J,Ameijide A, Siesling S, Mangone
L, Ardanaz E, Hédelin G, Mateos A, Micheli A, Sant M; EUROCARE Working Group. Predictions of
survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer.
2013 May 15;132(10):2404-12.
18. Allemani C; Sant M; Weir HK; Richardson LC; Baili P; Storm H; Siesling S; Torrella-Ramos A; Voogd
AC; Aareleid T; Ardanaz E; Berrino F; Bielska-Lasota M; Bolick S; Cirilli C; Colonna M; Contiero P; Cress
R; Crocetti E; Fulton JP; Grosclaude P; Hakulinen T; Izarzugaza MI; Malmström P; Peignaux K; PrimicŽakelj M; Rachtan J; Diba CS; Sánchez MJ; Schymura MJ; Shen T; Traina A; Tryggvadottir L; Tumino R;
Velten M; Vercelli M; Wolf HJ; Woronoff AS; Wu X; Coleman MP. Breast cancer survival in the US and
Europe: A CONCORD high-resolution study. Int J Cancer. 2013 Mar 1;132(5)
19. Maynadie' M; De Angelis R; Marcos-Gragera R; Visser O; Allemani C; Tereanu C; Capocaccia R; Giacomin
A; Lutz JM; Martos C; Sankila R; Børge Johannesen T; Simonetti A; Sant M. Survival of European patients
diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica. 2013 Feb;98(2):230-8
20. Baili P, Vicentini M, Tumino R, Vercelli M, Lorenzo M, Foschi R, Guzzinati S, Dal Maso L, Minicozzi P,
de Lorenzo F, Micheli A, Di Salvo F; The Caremore Group. A method for differentiating cancer prevalence
according to health status, exemplified using a population-based sample of Italian colorectal cancer cases.
Acta Oncol. 2013 Feb;52(2):294-302
21. Cortesi L, Marcheselli L, Guarneri V, Cirilli C, Braghiroli B, Toss A, Sant M, Ficarra G, Conte PF, Federico
M. Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients
with operable breast cancer diagnosed in recent years. Int J Cancer. 2013 Jan 15;132(2):E58-65
22. Minicozzi P, Caldarella A, Giacomin A, Ponz de Leon M, Cesaraccio R, Falcini F, Fusco M, Iachetta F,
Pellegri C, Tumino R, Capocaccia R, Sant M. Looking at differences in stage and treatment of colorectal
cancers across Italy: a EUROCARE-5 High Resolution study. Tumori 2012;98(6):671-677
23. Siesling S, Kwast A, Gavin A, Baili P, Otter R; EUROCHIP-3 Workpackage 5. Availability of stage at
diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for
cancer care in Europe: Results of EUROCHIP-3 survey. Int J Cancer. 2012 Nov 26. [Epub ahead of print]
24. Baili P, Hoekstra-Weebers J, Van Hoof E, Bartsch HH, Travado L, Garami M, Di Salvo F, Micheli A,
Veerus P; The EUROCHIP-3 Working group on Cancer Rehabilitation. Cancer rehabilitation indicators for
Europe. Eur J Cancer. 2012 Dec 10. [Epub ahead of print]
25. Sant M; Minicozzi P; Allemani C; Cirilli C; Federico M; Capocaccia R; Budroni M; Candela P; Crocetti E;
Falcini F; Ferretti F; Fusco M; Giacomin A; La Rosa F; Mangone L; Natali M; Ponz De Leon M; Traina A;
Tumino R; Zambon R. Regional inequalities in cancer care persist in Italy and can influence survival. Cancer
Epidemiol. 2012 Dec;36(6):541-7
26. Allemani C; Minicozzi P; Berrino F; Bastiaannet E; Gavin A; Galceran J; Ameijide A; Siesling S; Mangone
L; Ardanaz E; Hédelin G; Mateos A; Micheli A; Sant M; the EUROCARE Working Group. Predictions of
survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer.
2012 Oct 10 [Epub ahead of print]
27. Lhachimi SK, Cole KJ, Nusselder WJ, Smit HA, Baili P, Bennett K, Pomerleau J,McKee M,
Charlesworth K, Kulik MC, Mackenbach JP, Boshuizen H. Health impacts of increasing alcohol prices in
the European Union: a dynamic projection. Prev Med. 2012 Sep;55(3):237-43
28. Tereanu C; Baili P; Berrino F; Micheli A; Furtunescu FL; Minca DG; Sant M. Recent trends of cancer
mortality in Romanian adults: mortality is still increasing; although young adults do better than the
middle-aged and elderly population. Eur J Cancer Prev 2012 Sep 9
29. Minicozzi P; Cirilli C; Federico M; Capocaccia R; Budroni M; Candela P; Falcini F; Fusco M; Giacomin A;
La Rosa F; Traina A; Tumino R; Sant M. Differences in stage and treatment of breast cancer across Italy
point to inequalities in access to and availability of proper care. Tumori. 2012 98(2):204-9
30. Sant M; Minicozzi P; Lagorio S; Børge Johannesen T; Marcos-Gragera R; Francisci S; the EUROCARE
Working Group. Survival of European patients with central nervous system tumors. Int J Cancer. 2012
Jul 1;131(1):173-185
31. Oberaigner W; Minicozzi P; Bielska-Lasota M; Allemani C; De Angelis R; Mangone L; Sant M; the
EUROCARE Working Group. Survival for Ovarian Cancer in Europe: The across-country variation did not
shrink in the past decade. Acta Oncologica 2012 Apr;51(4).441-53
32. Kulik MC; Nusselder WJ; Boshuizen HC; Lhachimi SK; Fernández E; Baili P; et al. Comparison of tobacco
control scenarios: quantifying estimates of long-term health impact using the DYNAMO-HIA modeling tool.
PLoS One. 2012;7(2):e32363. Epub 2012 Feb 23.
33. Lhachimi SK; Nusselder WJ; Smit HA; van Baal P; Baili P; et al. DYNAMO-HIA-A Dynamic Modeling
Tool for Generic Health Impact Assessments. PLoS One. 2012;7(5):e33317. Epub 2012 May 10
34. Marcos-Gragera R; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Maynadie M; Luminari S; et al.
Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the
HAEMACARE project. Haematologica 2011; May 96(5):720-8
35. Zigon G, Berrino F, Gatta G, Sánchez MJ, van Dijk B, Van Eycken E, Francisci S; EUROCARE Working
Group. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999. a population-based study.
Ann Oncol. 2011;22(1).165-74
36. Micheli A, Di Salvo F, Lombardo C, Ugolini D, Baili P, Pierotti M.A.: Cancer research performance in the
European Union: a study of published output from 2000 to 2008. Tumori 2011; 97(6): 683-689
37. Allemani C, Berrino F, Krogh V, Sieri S, Pupa S.M, Tagliabue E, Tagliabue G, Sant M.
Do pre-diagnostic drinking habits influence breast cancer survival? Tumori 2011; 97(2):142-148
38. Kivistik A, Lang K, Baili P, Anttila A, Veerus P.: Women's knowledge about cervical cancer risk factors;
screening; and reasons for non-participation in cervical cancer screening programme in Estonia. BMC
Womens Health 2011; Sep 28
39. Secreto G, Meneghini E, Venturelli E, Cogliati P, Agresti R, Ferraris C, Gion M, Zancan M, Fabricio A.S.C,
Berrino F, Cavalleri A, Micheli A.: Circulating sex hormones and tumor characteristics in postmenopausal
breast cancer patients. A cross-sectional study. Int J Biol Markers 2011; 26: 241-246
40. Sant M, Karjalainen-Lindsberg M.L, Maynadiè M, Raphael M, Ferretti S, Giacomin A, Tereanu C, GiraldoCastellano P, Gragera R.M, Martos-Jimènez C, Lutz J.M, Visser O, Allemani C, De Angelis R, Berrino F,
Sowe S, Margutti C, Crosignani P, Ward D. Manual for coding and reporting haematological malignancies.
Tumori 2010; Jul 96(4)
41. Apostol I, Baban A, Nicula F, Suteu O, Coza D, Amati C, Baili P; EUROCHIP Working Group. Cervical
cancer assessment in Romania under EUROCHIP-2. Tumori. 2010 Jul-Aug;96(4):545-52.
42. Valerianova Z, Panayotova Y, Amati C, Baili P; EUROCHIP Working Group. Cervical cancer screening in
Bulgaria--past and present experience. Tumori. 2010 Jul-Aug;96(4):538-44.
43. Viberga I, Engele L, Baili P; EUROCHIP Working Group. Past, present and future of the cervical cancer
screening in Latvia. Tumori. 2010 Jul-Aug;96(4):529-37.
44. Veerus P, Arbyn M, Amati C, Paolo B; EUROCHIP Working Group. Impact of implementing a nationwide
cervical cancer screening program on female population coverage by Pap-tests in Estonia. Tumori. 2010 JulAug;96(4):524-8.
45. Marcos-Gragera R, Cervantes-Amat M, Vicente M.L, de Sanjose S, Guallar E, Godoy C, Calvo C, Giraldo P,
Sant M, Peris-Bonet R, Martos M.C. Population-based incidence of childhood leukaemias and lymphomas
in Spain (1993-2002). Eur J Cancer Prev 2010 Jul; 19. 247-255
46. Lepage C, Ciccolallo L, De Angelis R, Bouvier AM, Faivre J, Gatta G; EUROCARE working group.
European disparities in malignant digestive endocrine tumours survival. Int J Cancer 2010 Jun 15; 126.
2928-2934
47. Lepage C, Sant M, Verdecchia A, Forman D, Esteve J, Faivre J, and the EUROCARE working group.
Operative mortality after gastric cancer resection and long-term survival differences across Europe. Br J Surg
2010; 97. 235-239
48. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Simonetti A,
the HAEMACARE Working Group; et al. Incidence of hematologic malignancies in Europe by morphologic
subtype: results of HAEMACARE project. Blood 2010; Nov 11;116(19):3724-34
49. Bouvier A.M, Sant M, Verdecchia A, Forman D, Damhuis R, Coebergh J.W, Crocetti E, et al.
What reasons lie behind long-term survival differences for gastric cancer within Europe?
Eur J Cancer. 2010 Apr;46(6):1086-92
50. Lepage C, Sant M, Verdecchia A, Forman D, Esteve J, Faivre J, the EUROCARE Working Group.
Operative mortality after gastric cancer resection and long-term survival differences across Europe. Br J
Surg. 2010 Feb;97(2):235-9
51. Micheli A; Baili P; Ciampichini R; Verdecchia A. Evaluating the outcomes of cancer control. In Elwood
JM; Sutcliffe AB (Ed) Cancer control. Oxford university press; New York
52. Anttila A, Arbyn M, Veerus P, Viberga I, Kurtinaitiene R, Valerianova Z, Apostol I, Baili P, Micheli A.
Barriers in cervical cancer screening programs in new European Union member states. Tumori 2010;96(4):
515-516
53. Apostol I; Baban A; Nicula F; Suteu O; Coza D; Amati C, Baili P, Micheli A, Amati C, Casella I, Cifalà A,
Esposito M, Saltarelli S, Di Salvo F, Berrino F, Gatta G, Sant M, Ciccolallo L, Allemani C, on behalf of the
EUROCHIP Working Group. Cervical cancer screening in Bulgaria - past and present experience. Tumori
2010; 96(4): 545-552
54. Arbyn M, Antoine J, Valerianova Z, Magi M, Stengrevics A, Smailyte G, Suteu O, Micheli A.: Trends in
cervical cancer incidence and mortality in Bulgaria; Estonia; Latvia; Lithuania and Romania. Tumori 2010;
96(4): 517-523
55. Endogenous Hormones and Breast Cancer; Collaborative Group; Key T.J, Appleby P.N, Reeves G.K,
Roddam A.W, Krogh V, Micheli A, Berrino F. Insulin-like growth factor 1 (IGF1); IGF binding protein 3
(IGFBP3); and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol
2010; 11: 530-542
56. Schernhammer E.S, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Grioni S, Sempos C.T,
Cavalleri A, Schunemann H.J, Strano S, Muti P. Urinary 6-Sulphatoxymelatonin levels and risk of breast
cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2010; 19: 729737
57. Valerianova Z; Panayotova Y; Amati C; Baili P. Cervical cancer screening in Bulgaria - past and present
experience. Tumori 2010;96(4): 538-544
58. Viberga I; Engele L; Baili P. Past; present and future of the cervical cancer screening in Latvia. Tumori.
2010;96(4):529-37
59. Veerus P, Arbyn M, Amati C, Baili P Micheli A, Baili P, Amati C, Casella I, Cifalà A, Esposito M, Saltarelli
S, Di Salvo F, Ciampichini R, Berrino F, Gatta G, Sant M, Ciccolallo L, Allemani C, on behalf of the
EUROCHIP Working Group. Impact of implementing a nationwide cervical cancer screening program on
female population coverage by Pap-tests in Estonia. Tumori 2010;96(4): 524-528
60. Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza I, Torrella-Ramos A, Bielska-Lasota M, Aareleid T,
Ardanaz E, Colonna M, Crocetti E, Danzon A, Federico M, Garau I, Grosclaude P, Hédelin G, MartinezGarcia C, Peignaux K, Plesko I, Primic-Zakelj M, Rachtan J, Tagliabue G, Tumino R, Traina A,
Tryggvadóttir L, Vercelli M, Sant M. Variation in 'standard care' for breast cancer across Europe: a
EUROCARE-3 high resolution study. Eur J Cancer. 2010 Jun;46(9):1528-36.
61. Berrino F, Verdecchia A, Lutz J.M, Lombardo C, Micheli A, Capocaccia R, the EUROCARE Working
Group. Comparative cancer survival information in Europe. Eur J Cancer. 2009 Apr;45(6):901-8 (No
abstract)
62. De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A, the EUROCARE Working Group, et
al. The EUROCARE-4 database on cancer survival in Europe: Data standardisation; quality control and
methods of statistical analysis. Eur J Cancer. 2009;45:909-930.
63. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, Pastore G, Peris-Bonet R, Stiller
CA; EUROCARE Working Group. Survival of European children and young adults with cancer
diagnosed 1995-2002.Eur J Cancer. 2009;45(6).992-1005.
64. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, the EUROCARE Working
Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur
J Cancer. 2009;45:931-991.
65. Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M, Allemani C, Colonna M, Grande
E, Grosclaude P, Vercelli M, the EUROCARE Working Group. The cancer survival gap between elderly
and middle-aged patients in Europe is widening. Eur J Cancer. 2009;45:1006-1016.
66. Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta G, De
Angelis R, the EUROCARE Working Group. The advantage of women in cancer survival: An analysis of
EUROCARE-4 data. Eur J Cancer. 2009;45:1017-1027.
67. Brenner H, Francisci S, De Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Sant M, the
EUROCARE Working Group, et al. Long-term survival expectations of cancer patients in Europe in 20002002. Eur J Cancer. 2009;45:1028-1041.
68. Ciccolallo L, Licitra L, Cantú G, Gatta G; EUROCARE Working Group. Survival from salivary glands
adenoid cystic carcinoma in European populations. Oral Oncol, 2009;45(8).669-74.
69. Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant
M, the EUROCARE Working Group. Survival trends in European cancer patients diagnosed from 1988 to
1999. Eur J Cancer. 2009;45:1042-1066.
70. Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, Gatta G, Sant M, Zigon G,
Bray F, Janssen-Heijnen M, the EUROCARE Working Group. The cure of cancer: A European
perspective. Eur J Cancer. 2009;45:1067-1079.
71. Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A;
Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P. Sex hormone levels; breast cancer risk; and
cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev.
2009;18(1):169-76
72. Luciani S; Vardy L; Paci E; Adewole I; Sasco A; Calvacante T; ICCC-3 Session C Group. Cancer
prevention and population-based screening. Tumori 2009;95(5):597-609
73. Verdecchia A; Santaquilani M; Sant M. Survival for cancer patients in Europe. Ann Ist Super Sanità.
2009;45(3):315-24
74. Kerner JF; Cazap E; Yach D; Pierotti MA; Daidone MG; de Blasio P; Geary P; Schacter B; Sant M;
Habbema JD; Sankaranarayanan R; Sutcliffe C; Sutcliffe S; ICCC-3 Session D Group. Comprehensive
cancer control-research & development: knowing what we do and doing what we know. Tumori.
2009;95(5):610-22.
75. Capocaccia, R, Gavin, A, Hakulinen, T, Lutz, J. M, and Sant M. eds. Survival of Cancer Patients in
Europe 1995-2002.The EUROCARE-4 Study. Eur J Cancer 2009,45(6), 901-1094 (special issue)
76. Micheli A; Sanz N; Mwangi-Powell F; Coleman MP; Neal C; Ullrich A; Travado L; Santini LA; Grassi L;
De Lorenzo F; Costa A; Dangou JM; Bisanti L; Seniori Costantini A; Abu-Rmeileh N; Kamal M; Federico
M; Saracci R; Rennert G; Stefanini A; Cavalli F; Cazap E; Redmond K; O'Reilly S; Muti P; Casali P; Gatta
G; Ferrari A; Koifman S; Bah E; Pastore G; Barr R; Lombardo C; Frazzingaro C; Ciampichini R; Baili P;
ICCC-3 Session B Group. International collaborations in cancer control and the Third International Cancer
Control Congress. Tumori. 2009;95(5):579-96
77. Harford JB; Edwards BK; Nandakumar A; Ndom P; Capocaccia R; Coleman MP; ICCC-3 Session A
Group. Cancer control-planning and monitoring population-based systems. Tumori 2009;95(5):568-78.
78. Formelli F; Meneghini E; Cavadini E; Camerini T; Di Mauro MG; De Palo G; Veronesi U; Berrino F;
Micheli A. Plasma retinol and prognosis of postmenopausal breast cancer patients. Cancer Epidemiol
Biomarkers Prev 2009 18(1):42-8.
79. Pierotti MA; Micheli A; Sutcliffe SB. The 3rd International Cancer Control Congress: international
collaboration in an era of cancer as a global concern. Tumori 2009; 95(5):565-7.
80. Micheli A; Di Salvo F; Lombardo C; Ciampichini R; Ugolini D; Baili P; Pierotti MA. Italian performance
in cancer research. Tumori 2009; 95(2):133-41
81. Fateh-Moghadam P; Agostini D, Baussano I, Bertozzi N, Canova C, Castellazzi F, Chatenoud L, Checchi F,
Cislaghi C, D'Ancona P, Fateh-Moghadam P, Filoni A, Francisci S, Gasparrini A, Gennaro V, Gigli A,
Gorini G, Martiello MA, Mensi C, Miligi L, Mondo L, Panizza C, Pasetto R, Petrella M, Randi G, Saltarelli
S, Stefanini A, Terracini B, Trinito M, Vigotti MA. [Activities of the Group of the Italian Association of
Epidemiology on violent conflicts]. Epidemiol Prev. 2009 May-Jun;33(3):76-7.
82. Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F;
Cavalleri A; Micheli A. Testosterone and biological characteristics of breast cancers in postmenopausal
women. Cancer Epidemiol Biomarkers Prev 2009 Nov;18(11):2942-8.
83. Sant. M, Allemani C, De Angelis R, Carbone A, De Sanjosè S, Gianni A.M, Giraldo P, Marchesi F, MarcosGragera R, Martos-jimenez C, Maynadié M, Raphael M, Berrino F, EUROCARE-3 Working Group.
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States. Eur J
Cancer. 2008; 44:579-587.
84. Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C Meningioma Crit Rev in Oncol/
Hemat, 2008; 67. 153-171
85. Coleman M, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G,
Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, Francisci S, Santaquilani
M, Verdecchia A, Storm HH, Young JL Cancer survival in five continents. a worldwide populationbased study (CONCORD) Concord Working Group Lancet Onc, 2008 9(8).730-56
86. Baili P, Micheli A, De Angelis R, Weir HK, Francisci S, Santaquilani M, Hakulinen T, Quaresmas M,
Coleman MP; CONCORD Working Group. Life tables for world-wide comparison of relative survival
for cancer (CONCORD study).Tumori, 2008;94(5).658-68
87. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E; EUROCARE
Working Group. Survival in patients with uveal melanoma in Europe. Arch Ophthalmol, 2008;
126(10).1413-8
88. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in
Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncology 2007;8:784-796.
89. Berrino F, De Angelis R, Sant M, Rosso S, Lasota M.B, Coebergh J.W, et al. Survival for eight major
cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4
study. Lancet Oncol. 2007 Sep;8(9):773-83.
90. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F, et al. Hepatocellular carcinoma: trends
of incidence and survival in Europe and United States at the end of the 20th century. Am J Gastroenterol.
2007;102:1661-1670.
91. Quaglia A, Capocaccia R, Micheli A, Carrani E, Vercelli M, the EUROCARE-3 Working Group.
A wide difference in cancer survival between middle aged and elderly patients in Europe.
Int J Cancer 2007;120:2196-2201.
92. Sant M, Allemani C, Sieri S, Krogh V, Menard S, Tagliabue E, Nardini E, Micheli A, Crosignani P, Muti P,
Berrino F. Salad vegetables dietary pattern protects against HER-2-positive breast cancer. A prospective
Italian study Int J Cancer, 2007; 121. 911-914
93. Sant M, Aareleid T, Artioli ME, Berrino F, Coebergh JW, Colonna M, Forman D, Hedèlin G, Rachtan J,
Lutz JM, Otter R, Raverdy N, Plesko I I, Primic MZ, Tagliabue G. Ten-year survival and risk of relapse for
testicular cancer. a EUROCARE high resolution study.Eur J Cancer, 2007 Feb;43(3).585-92
94. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisan F Hepatocellular carcinoma. trends of
incidence and Survival in Europe and the United States at the end of the 20th Century. EUROCARE
Working Group. Am J of Gastr, 2007; 102. 1661-1670
95. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M; EUROCARE
Working group. Survival for eight major cancers and all cancers combined for European adults diagnosed in
1995-99. results of the EUROCARE-4 study. Lancet Oncol, 2007 ;8(9).773-83. Erratum in. Lancet Oncol.
2007;8(10).868. Lasota, Magdalena B
96. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Time trends of breast cancer
survival in Europe in relation to incidence and mortality. Int J Cancer. 2006 Nov 15;119(10).2417-22
97. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Should we use incidence, survival
or mortality to assess breast cancer trends in European women? Nat Clin Pract Oncol , 2006;3. 228-229
98. Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon A,
Federico M, Gafa L, Grosclaude P, Hedelin G, Mace-Lesech J, Garcia CM, Paci E, Raverdy N, Tretarre B,
Williams EM Prognostic value of morphology and hormone receptor status in breast cancer - a populationbased study. Br J Cancer ,2004 91. 1263-1268
99. Allemani C, Sant M, De Angelis R, Gragera R.M, Coebergh J.W, the Eurocare Working Group.
Hodgkin disease survival in Europe and the U.S. Cancer 2006;107:352-360.
100. Sant M, Allemani C, Berrino F, Coleman M.P, Aareleid T, et al. Breast carcinoma survival in Europe and
the United States – A population-based study. Cancer 2004;100:715-722.
101. Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T,
Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D.
EUROCARE-3. survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol,
2003;14 Suppl 5.v61-118.
102. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani
M, Berrino F and EUROCARE Working Group. EUROCARE-3 summary. cancer survival in Europe at the
end of the 20th century (no abs). Ann Oncol, 2003;14 Suppl 5.v128-49.
103. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh J.W, Coleman M.P, Grosclaude P,
Martinez C, Bell J, Youngson J, Berrino F. Stage at diagnosis is a key explanation of differences in breast
cancer survival across Europe. Int J Cancer 2003 Sep 1;106(3):416-22.
104. Forman D, Stockton D, Møller H, Quinn M, Babb P, De Angelis R, Micheli A. Cancer prevalence in the
UK: results from the EUROPREVAL study. Ann Oncol. 2003;14:648-654.
105. Micheli A, Yancik R, Krogh V, Verdecchia A, Sant M, Capocaccia R, Berrino F, Ries L. Contrasts in
cancer prevalence in Connecticut, Iowa, and Utah. Cancer 2002; 15;95.430-9.
106. Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza M.I, Paci E. A comparative analysis of cancer
prevalence in cancer registry areas of France; Italy and Spain. Ann Oncol. 2002;13:1128-1139.
107. Micheli A, Mugno E, Krogh V, Quinn M.J, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R.
Cancer Prevalence in European Registry Areas. Ann Oncol. 2002;13:840-865.
108. Capocaccia R, Colonna M, Corazzieri I, De Angelis R, Francisci S, Micheli A, Mugno E. Measuring cancer
prevalence in Europe: the EUROPREVAL Project. Ann Oncol. 2002;13:831-839.
109. Sant M and EUROCARE Working Group. Differences in stage and therapy for breast cancer across Europe.
Int J Cancer, 2001; 93.894-901
110. Sant M, Capocaccia R, Coleman M.P, Berrino F, Gatta G, Micheli A, Verdecchia A, et. al. Cancer survival
increases in Europe; but international differences remain wide. Eur J Cancer. 2001;37:1659-1667.
111. Verdecchia A, Mariotto A, Capocaccia R, Gatta G, Micheli A, Sant M, Berrino F. Incidence and prevalence
of all cancerous diseases in Italy. trends and implications. Eur J Cancer 2001; 37.1149-57.
112. Sant M, Capocaccia R, Badioni V. Survival for retinoblastoma in Europe. Eur J Cancer. 2001;37:730-735.
113. Berrino F, Gatta G, Sant M, Capocaccia R. The EUROCARE study of survival of cancer patients in Europe:
aims; current status; strengths and weaknesses. Eur J Cancer. 2001;37:673-677.
114. Gatta G, Capocaccia R, Coleman MP, Gloeckler Ries L.A, Hakulinen T, Micheli A, Sant M, Verdecchia A,
and Berrino F. Toward a Comparison of Survival in American and European Cancer Patients. Cancer
2000;89:893-900.
115. Gatta G, Capocaccia R, Sant M, Bell C.M.J, Coebergh J.W.W, Damhuis R.A.M, Faivre J, Martinez-Garcia
C, Pawlega J, Ponz de Leon M, Pottier D, Raverdy N, Williams E.M.I, Berrino F. Understanding variations
in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47:533-538.
116. Sant M. [Reference data on survival of cancer patients in 17 European countries]. Epidemiol Prev, 2000;
24.44-5. (no abs.)
117. Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A. (editors).
Survival of cancer patients in Europe: the EUROCARE-2 Study. IARC Scientific Publication 1999;151.
118. Gatta G, Capocaccia R, Hakulinen T, Sant M, Verdecchia A, De Angelis G, Micheli A, Berrino F.
Variations in survival for invasive cervical cancer among European women, 1978-89. EUROCARE Working
Group. Cancer Causes Control, 1999;10.575-81.
119. Sant M, Barchielli A, Francisci S, Canario F. The prevalence of tumors of the breast and female genital tract
in Italy. Tumori, 1999; 85.382-6.
120. Zanetti R, Micheli A, Rosso S, Sant M. The prevalence of cancer. a review of the available data. Tumori,
1999; 85.408-13.
121. Sant M, Berrino F, Coebergh JW. Cancer survival in Britain. Reliable data on stage distribution are
essential. BMJ, 1999; 11;319.1572-3 (no abs.)
122. Coebergh J W W, Sant M, Berrino F, Verdecchia A (eds). Survival of adult cancer patients in Europe
diagnosed from 1978-1989. The EUROCARE study. Eur J Cancer, 1998; 34. N° 14.
123. Sant M, van der Sanden G, Capocaccia R. Survival rates for primary malignant brain tumours in Europe.
Eur J Cancer. 1998;34:2241-2247.
124. Aareleid T, Sant M, Hédelin G. Improved survival for patients with testicular cancer in Europe since 1978.
Eur J Cancer. 1998;34:2236-2240. Document
125. Faivre J, Forman D, Estève J, Obradovic M, Sant M. Survival of patients with primary liver cancer;
pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer. 1998;34:2184-2190.
126. Coebergh J.W.W, Sant M, Berrino F, Verdecchia A. Survival of Adult Cancer Patients in Europe Diagnosed
from 1978-1989: The EUROCARE II Study. Eur J Cancer. 1998;34:2137-2138
127. Sant M. La sopravvivenza per carcinoma mammario. Attualità in senologia, 1998; 19. 5-9.
128. Sant M, Capocaccia R, Verdecchia A, Esteve J, Gatta G, Micheli A, Coleman MP, Berrino F. Survival of
women with breast cancer in Europe. variation with age, year of diagnosis and country. The EUROCARE
Working Group. Int J Cancer, 1998; 31;77.679-83
129. Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G. The cure for colon cancer: results
from the Eurocare Study. Int J Cancer 1998;77:322-329.
130. Micheli A, Gatta G, Sant M, Krogh V, Perone C, Dell'Era L, Saltarelli S, Berrino F. Breast cancer
prevalence measured by the Lombardy Cancer Registry. Tumori, 1997; 83.875-9
131. Berrino F, Micheli A, Sant M, Capocaccia R. Interpreting survival differences and trends. Tumori, 1997;
83.9-16
132. Capocaccia R, De Angelis R, Frova L, Gatta G, Sant M, Micheli A, Berrino F, Conti E, Gafa L, Roncucci L,
Verdecchia A. Estimation and projections of colorectal cancer trends in Italy. Int J Epidemiol, 1997; 26.92432.
133. Sant M, Gatta G, Valente F, Barchielli A, Ramazzotti V, Serventi L, Rosso S. The ITACARE Study.
Tumori, 1997; 83.17-24.
134. Gatta G, Sant M, Micheli A, Capocaccia R, Verdecchia A, Barchielli A, Gafa L, Ramazzotti V, Berrino F.
[Survival for digestive system tumors. Italian population-based data and international comparisons]. Ann Ist
Super Sanita, 1996; 32.513-25.
135. Ponz de Leon M, Micheli A, Gatta G, Capocaccia R, Sant M, Gafa L, Conti EM, Roncucci L, Berrino F.
[Survival for tumors of the colon and the rectum in Italy]. Ann Ist Super Sanita, 1996; 32.527-36
136. De Angelis R, Valente F, Frova L, Capocaccia R, Micheli A, Chessa E, Sant M. Incidence, mortality and
prevalence of stomach cancer in Italian regions. Tumori, 1996; 82.314-20.
137. Gatta G, Sant M, Coebergh JW, Hakulinen T. Substantial variation in therapy for colorectal cancer across
Europe. EUROCARE analysis of cancer registry data for 1987. Eur J Cance, 1996; 32A.831-5
138. Gatta G, Sant M. Survival of cancer patients in Europe. Guide to tables. IARC Sci Publ, 1995;132 .75-91.
139. Sant M, Gatta G. The EUROCARE database. IARC Sci Publ, 1995; 132.15-31.
140. Sant M, Gatta G, Barchielli A, Conti EM, Gafa L, Magnani C, Ponz de Leon M. Health care system, cancer
registration and follow-up of cancer patients in Italy. IARC Sci Publ, 1995; 132.60-2.
141. Sant M, Capocaccia R, Verdecchia V, Gatta G, Micheli A, Mariotto A, Hakulinen T, Berrino F,
EUROCARE Working Group. Comparison of colon-cancer survival among european countries:
the EUROCARE study. Int J Cancer 1995;63:43-48.
142. Capocaccia R, De Angelis R, Frova L, Sant M, Buiatti E, Gatta G, Micheli A, Berrino F, Barchielli A, Conti
E, et al. Estimation and projections of stomach cancer trends in Italy. Cancer Causes Control, 1995; 6.33946.
143. Berrino F, Sant M, Verdecchia V, Capocaccia R, Hakulinen T, Estéve J.(editors). Survival of cancer patients
in Europe: the EUROCARE Study. IARC Scientific Publication 1995;132.

Download Report